Core Points - The article discusses the expansion of short-term health insurance plans under the Trump administration as a response to rising healthcare costs and the expiration of enhanced ACA subsidies in 2026 [6][10] - Short-term plans are cheaper than ACA coverage but lack essential health benefits and protections for preexisting conditions, leading to concerns about their adequacy [11][12] Group 1: Short-Term Insurance Plans - Short-term health insurance plans, also known as "short-term limited duration insurance," are designed to provide temporary coverage for individuals between other insurance options [4] - The Trump administration's 2018 executive order allowed these plans to last up to three years, significantly extending their duration compared to the previous limit of four months [1][10] - These plans are typically about half the cost of ACA plans, with a 40-year-old nonsmoker in Florida paying approximately $320 for short-term coverage compared to $500 for ACA coverage [11] Group 2: Regulatory Changes and Consumer Impact - The Biden administration tightened regulations on short-term plans in 2024, limiting their duration to four months and requiring clearer disclosures about coverage limitations [10] - Critics argue that short-term plans can mislead consumers into thinking they have comprehensive coverage, which they do not, leading to potential financial risks [5][13] - Some states, including New York and California, have banned the sale of short-term plans due to their inadequate coverage [12] Group 3: Market Reactions and Consumer Choices - The article highlights a divide in opinions regarding short-term plans, with some officials advocating for their expansion as a cost-saving measure for those excluded from the ACA [7] - Consumers are encouraged to assess their health needs and consider high-deductible plans paired with health savings accounts as alternatives to short-term insurance [14][15] - The article emphasizes the importance of understanding the limitations of short-term plans and suggests that they should only be viewed as temporary solutions [17]

Core Viewpoint - Rosen Law Firm is urging investors of Molina Healthcare, Inc. to secure legal counsel before the December 2, 2025 deadline for a securities class action lawsuit related to undisclosed adverse facts affecting the company's financial guidance and operations [1][5]. Group 1: Class Action Details - The class action pertains to Molina securities purchased between February 5, 2025, and July 23, 2025, with a lead plaintiff deadline set for December 2, 2025 [1][2]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. Group 2: Allegations Against Molina - The lawsuit claims that Molina failed to disclose critical information regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [5]. - It is alleged that Molina's growth was reliant on limited utilization of various health services, which could lead to a significant cut in financial guidance for fiscal year 2025 [5]. - The lawsuit asserts that positive statements made by Molina regarding its business and prospects were materially misleading due to the undisclosed adverse facts [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company and being ranked highly for securities class action settlements [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen has been recognized as a leading figure in the plaintiffs' bar, highlighting the firm's expertise in this area [4].

Accessibility StatementSkip Navigation NEW YORK, Dec. 2, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), of the important December 2, 2025 lead plaintiff deadline. So What: If you purchased Molina securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs thr ...

Dec 2, 2025 9:49 AM Eastern Standard Time FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare Share Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directl ...

"We're committed to improving access to healthy food and to making a difference in people's lives," said Cristal Gary, Meridian Plan President and CEO. "Through this partnership with the St. Louis Area Foodbank, Food On The Move creates a vital pipeline to combat food insecurity and improve health outcomes. Together, we can deliver critical food and health resources directly to those who need them most." In 2024, Food On The Move provided support to roughly 12,000 individuals across 4,300 households. By Ma ...

Curative, a startup health insurance company that aims to reduce costs by encouraging people to get preventative care, has raised more than $150 million in a bid to redesign how employer health benefits work https://t.co/FPeC2QBfsK ...

Core Insights - CGI has renewed and expanded its partnership with Highmark Inc., focusing on enhancing payment integrity through the CGI ProperPay platform, which has been in place for over a decade [1][2][3] Partnership Details - The new contract includes enhanced data analytics and recovery audit capabilities to support Highmark's claims review initiatives, resulting in year-over-year improvements in recoveries and a 98% uphold rate on audit findings [2][3] - Highmark has reported measurable increases in average savings per review on inpatient claims while maintaining operational efficiency and strengthening provider relationships due to the partnership with CGI [3] Technological Advancements - CGI's ProperPay platform utilizes predictive modeling and case selection optimization to improve audit capabilities, contributing to the overall success of Highmark's payment accuracy efforts [3] - CGI is exploring the introduction of new AI-powered capabilities to further enhance outcomes and automate high-volume review workflows [4] Company Overview - CGI is one of the largest independent technology and professional services firms globally, with reported revenue of CA$15.91 billion for fiscal 2025 and a workforce of 94,000 professionals [4]

When insurance bills start arriving with six-figure totals, it's already too late. That's the harsh lesson learned by Americans who purchased what seemed like legitimate health insurance — only to discover after surgery that their "affordable" policies were nearly worthless. An Arkansas salesman faces $116,000 in bills for neck surgery. A Wyoming retiree owes $82,000 after heart failure treatment. A Florida chef is stuck with over $100,000 for knee replacement. All three purchased short-term health plans ...

Core Insights - The U.S. healthcare industry is currently facing significant challenges, including political battles over the Affordable Care Act (ACA) subsidies and rising healthcare costs impacting consumers [1][4] - UnitedHealth Group has experienced a nearly 50% decline in stock price due to various issues, including the death of its CEO and rising Medicare costs [2][3] - The company is implementing strategies to stabilize profits, including raising premiums and shedding unprofitable business segments, which may lead to a loss of up to 1 million Medicare Advantage members [6][7] Industry Overview - The ongoing political debate regarding the renewal of ACA subsidies is critical, as the expiration of these subsidies could lead to increased premiums for consumers [4] - Rising living expenses and healthcare costs are straining consumers, making healthcare a contentious issue in the U.S. [1] Company Performance - UnitedHealth Group reported a significant drop in operating margin from 5.6% to 2.1% in the third quarter due to unexpected care costs in its Medicare business [3] - The company is raising premiums for ACA exchange policies by an average of 25%, which could reduce enrollment by up to two-thirds [7] Financial Outlook - Management has slightly increased the full-year earnings guidance from $16.00 to $16.25 per share, with long-term earnings growth expected at an annualized rate of 13% to 16% [9] - The stock trades at over 20 times the updated earnings guidance, presenting a compelling price-to-earnings ratio with a PEG ratio of 1.25 to 1.50 [10] - Even with a conservative growth estimate of 10%, the stock maintains a reasonable PEG ratio of 2.0, indicating some margin of safety [11] Risks and Considerations - The primary threat to UnitedHealth Group is the potential for government intervention in the healthcare sector, which remains a contentious issue during elections [12] - Despite negative publicity and allegations of misconduct, the company is viewed as a key player in a profitable industry, suggesting it may be undervalued at present [12]

UnitedHealth Group has reached an agreement to divest its South American unit Banmedica to private equity group Patria Investments for $1bn (CI$831.99m), reported Reuters, citing sources. UnitedHealth began its efforts to exit Latin America in 2022, having already divested its operations in Brazil and Peru. Discussions regarding the sale of Banmedica have taken place over nearly one year. Banmedica operates in Colombia and Chile. By June, after its withdrawal from Peru, Banmedica reported 1.7 million h ...